The FDA has issued a Complete Response Letter to Scholar Rock regarding the BLA for apitegromab for the treatment of spinal muscular atrophy.

Alzheimer disease risk was up to 32% with early estrogen initiation, but an increased risk for dementia was seen among older women.

Frailty and prefrailty were associated with significantly increased risk for dementia compared with nonfrailty.

A subset of patients with PsA achieved rapid and sustained remission following treatment with b/tsDMARDs and were classified as a super-responder phenotype.

There were 5.7 million more childless women of prime childbearing age in 2024 compared with fertility patterns prior to the Great Recession.

HealthDay News — Cocoa extract supplementation yields a significant reduction in high-sensitivity C-reactive protein (hsCRP) and an increase in interferon-γ (IFN-γ), while no significant effects are ...

This patient perspective entails a first-hand experience of fatphobia and weight-inclusive health care in the clinical setting.

The FDA has granted Fast Track designation to SAR446268 for the treatment of non-congenital myotonic dystrophy type 1.

Patients with PsA have a higher prevalence of MetS compared with members of the general population and individuals with other inflammatory arthropathies.

Patients with D2T-PsA can be stratified into inflammatory and noninflammatory phenotypes, with the former linked to higher sonographic activity.

Among US adults, 34.9% reported 1 cardiovascular disease risk factor and 28.7% reported two or more cardiovascular disease risk factors.

Virus detection rates were highest among pre-K and elementary students, followed by middle school students, high school students, and staff.